Xtrem Biotech
-
DATABASE (56)
-
ARTICLES (44)
WWF-backed biotech Oceanium has developed a biorefinery that transforms seaweed into alt-proteins and compostable packaging that will soon be launched commercially.
WWF-backed biotech Oceanium has developed a biorefinery that transforms seaweed into alt-proteins and compostable packaging that will soon be launched commercially.
Biotech Bluepha has secured close to $100m Series B funding to boost bioplastics production and R&D to develop greener solutions for industrial manufacturers.
Biotech Bluepha has secured close to $100m Series B funding to boost bioplastics production and R&D to develop greener solutions for industrial manufacturers.
CEO and co-founder of String Bio
Ezhil Subbian studied industrial biotechnology at Anna University in India. She then went to the US to complete two PhDs in biochemistry, biophysics and molecular biology at the Oregon Health & Science University and from Rutgers, the State University of New Jersey-New Brunswick. She was a research assistant at both universities.While in the US, she was also a research scientist at Gevo Inc and at Vollum Institute. In 2008, she became a scientist and technical lead at pharma Codexis in California. In 2011, she worked at San Francisco-based Kumar Investments as an entrepreneur and biotech consultant.In 2012, she founded biotech startup String Inc while on a nine-month Startup Leadership Program in Silicon Valley. In June 2013, she and husband returned to India and formed a new company String Bio to continue working on the alternative protein powder project for animal feed production.
Ezhil Subbian studied industrial biotechnology at Anna University in India. She then went to the US to complete two PhDs in biochemistry, biophysics and molecular biology at the Oregon Health & Science University and from Rutgers, the State University of New Jersey-New Brunswick. She was a research assistant at both universities.While in the US, she was also a research scientist at Gevo Inc and at Vollum Institute. In 2008, she became a scientist and technical lead at pharma Codexis in California. In 2011, she worked at San Francisco-based Kumar Investments as an entrepreneur and biotech consultant.In 2012, she founded biotech startup String Inc while on a nine-month Startup Leadership Program in Silicon Valley. In June 2013, she and husband returned to India and formed a new company String Bio to continue working on the alternative protein powder project for animal feed production.
New York-based Humboldt Fund invests in startups with the potential to solve critical issues of our time across the areas of food production, healthcare, energy, and construction and manufacturing materials. It currently has 14 companies in its portfolio. Its most recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech, and in the February 2021 $16m seed round of US biotech Cellino Biotech.
New York-based Humboldt Fund invests in startups with the potential to solve critical issues of our time across the areas of food production, healthcare, energy, and construction and manufacturing materials. It currently has 14 companies in its portfolio. Its most recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech, and in the February 2021 $16m seed round of US biotech Cellino Biotech.
Founded in 2011, the knowledge capital fund is an initiative from the InKemia IUCT Group to focus on innovation and the licensing of patents in the biotech sectors. InKemia supports the life science industry through R&D grant programs, technical consultancy and training. It specializes in areas such as chemical synthesis, biotech, bio-catalysis, quality control and EU releases of new products. InKemia also supports local entrepreneurs through the Manuel Arroyo Award for Young Entrepreneurs with the aim to promote local cooperative economic development.
Founded in 2011, the knowledge capital fund is an initiative from the InKemia IUCT Group to focus on innovation and the licensing of patents in the biotech sectors. InKemia supports the life science industry through R&D grant programs, technical consultancy and training. It specializes in areas such as chemical synthesis, biotech, bio-catalysis, quality control and EU releases of new products. InKemia also supports local entrepreneurs through the Manuel Arroyo Award for Young Entrepreneurs with the aim to promote local cooperative economic development.
Jeffrey Leiden is a physician and scientist of more than 40 years, who is currently the executive chairman of US-based multinational biotech company Vertex Pharmaceuticals. Leiden is also the chairman of Casana, a remote healthcare platform and the chairman of Tmunity, a biotech dedicated to T-cell research. In March 2021, he participated as an angel investor in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
Jeffrey Leiden is a physician and scientist of more than 40 years, who is currently the executive chairman of US-based multinational biotech company Vertex Pharmaceuticals. Leiden is also the chairman of Casana, a remote healthcare platform and the chairman of Tmunity, a biotech dedicated to T-cell research. In March 2021, he participated as an angel investor in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
Co-founder, CTO of Polaroo
Sergio Sanchez is the CTO and co-founder of Widuid that was later re-branded as Polaroo, a Spanish household bill management app. He spent eight months working on building the MVP with the Rovira brothers in 2017.The mechanical engineer also completed a master's in Automatic Control and Robotics at his alma mater, the Polytechnic Degree of Barcelona. Like fellow co-founder Marc Rovira, Sanchez was also at space tech startup Zero2Infinity working as a full stack developer and HMI engineer. He has also worked in biotech company Fungitech Global as a mechanical engineer.
Sergio Sanchez is the CTO and co-founder of Widuid that was later re-branded as Polaroo, a Spanish household bill management app. He spent eight months working on building the MVP with the Rovira brothers in 2017.The mechanical engineer also completed a master's in Automatic Control and Robotics at his alma mater, the Polytechnic Degree of Barcelona. Like fellow co-founder Marc Rovira, Sanchez was also at space tech startup Zero2Infinity working as a full stack developer and HMI engineer. He has also worked in biotech company Fungitech Global as a mechanical engineer.
Karnataka Information and Biotechnology Venture Fund (KITVEN)
Founded in 1999, KITVEN is a state investor in startups in the Indian state of Karnataka. Major investment sectors include biotech, animation, visual effects, electronics, manufacturing, gaming and comics. Based in Bengaluru, the office is run by Karnataka Asset Management Company Private Limited.KITVEN has invested in more than 50 startups. In 2019, the VC invested in String Bio’s Series A round and joined the $2.2m seed round of smart lock startup Open App. Backed by state and central government financial institutions, the VC manages five funds: KITVEN Fund, KITVEN Fund 2, KITVEN Fund 3 Biotech, KITVEN Fund 4 and Karnataka Semiconductor Venture Capital Fund (KARSEMVEN Fund).
Founded in 1999, KITVEN is a state investor in startups in the Indian state of Karnataka. Major investment sectors include biotech, animation, visual effects, electronics, manufacturing, gaming and comics. Based in Bengaluru, the office is run by Karnataka Asset Management Company Private Limited.KITVEN has invested in more than 50 startups. In 2019, the VC invested in String Bio’s Series A round and joined the $2.2m seed round of smart lock startup Open App. Backed by state and central government financial institutions, the VC manages five funds: KITVEN Fund, KITVEN Fund 2, KITVEN Fund 3 Biotech, KITVEN Fund 4 and Karnataka Semiconductor Venture Capital Fund (KARSEMVEN Fund).
One of the earliest VC/PE firms in China, Shenzhen GTJA Investment focuses on the healthcare/biotech industry. It manages about RMB 10 billion and has invested in more than 100 companies since its inception in 2001.
One of the earliest VC/PE firms in China, Shenzhen GTJA Investment focuses on the healthcare/biotech industry. It manages about RMB 10 billion and has invested in more than 100 companies since its inception in 2001.
CEO and co-founder of Because Animals
Shannon Falconer graduated with a master’s in botany at the University of Vancouver in 2006. She also completed a PhD in biochemistry at The McMaster University in 2014. She went on to work as a postdoctoral researcher at Stanford University until 2016 when she decided to become the CEO and co-founder of biotech startup Because Animals. She also led the biotech’s R&D team to develop plant-based nutritional cookies and treats for dog and cats. Because Animals now aims to produce the world’s first cell-based cultured meat products for pets.
Shannon Falconer graduated with a master’s in botany at the University of Vancouver in 2006. She also completed a PhD in biochemistry at The McMaster University in 2014. She went on to work as a postdoctoral researcher at Stanford University until 2016 when she decided to become the CEO and co-founder of biotech startup Because Animals. She also led the biotech’s R&D team to develop plant-based nutritional cookies and treats for dog and cats. Because Animals now aims to produce the world’s first cell-based cultured meat products for pets.
DSM Venturing is the investment arm of major Dutch biotech company DSM that has been investing in startups since 2006. The company currently has 36 startups in its portfolio across geographies and has managed three exits to date. It typically invests between €100,000 and €5m, with a lifetime investment varying from €1m–20m and usually requires board membership alongside investment. It has offices in the Netherlands and the US, both on the east and west coast. Its recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech, and in the same month, in the $8m Series A round of British anti-pollution biotech Deep Branch Biotechnology.
DSM Venturing is the investment arm of major Dutch biotech company DSM that has been investing in startups since 2006. The company currently has 36 startups in its portfolio across geographies and has managed three exits to date. It typically invests between €100,000 and €5m, with a lifetime investment varying from €1m–20m and usually requires board membership alongside investment. It has offices in the Netherlands and the US, both on the east and west coast. Its recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech, and in the same month, in the $8m Series A round of British anti-pollution biotech Deep Branch Biotechnology.
Green Innovations is an impact fund that invests in large-scale projects addressing global sustainability challenges, focusing on the agriculture, biotechnology, education, energy, housing and water sectors. It is headed by Angola-based Portuguese businessman Jorge Marques, and linked to Israeli group Mitrelli. Green Innovations took control of Biocant, Portugal’s biggest biotech park, in a privatization move in 2017–2018. Green Innovations's stable of companies includes Green Biotech, created to invest in biotechnology in Portugal, and Green Services Innovations, linked to the exploration of phosphates in Congo.Its recent investments include in the June 2021 $85m Series C round and February 2021 $25m Series B of Portuguese home physiotherapy tech solution SWORD Health, the world’s fastest-growing musculoskeletal solution.
Green Innovations is an impact fund that invests in large-scale projects addressing global sustainability challenges, focusing on the agriculture, biotechnology, education, energy, housing and water sectors. It is headed by Angola-based Portuguese businessman Jorge Marques, and linked to Israeli group Mitrelli. Green Innovations took control of Biocant, Portugal’s biggest biotech park, in a privatization move in 2017–2018. Green Innovations's stable of companies includes Green Biotech, created to invest in biotechnology in Portugal, and Green Services Innovations, linked to the exploration of phosphates in Congo.Its recent investments include in the June 2021 $85m Series C round and February 2021 $25m Series B of Portuguese home physiotherapy tech solution SWORD Health, the world’s fastest-growing musculoskeletal solution.
CEO and co-founder of Zipline International
After graduating in economics and biotech at Harvard in 2009, Keller Rinaudo joined BCG in San Francisco but left to become a professional rock climber in November 2010. He has climbed alpine cliffs in France, underwater caves in Kentucky and the limestone towers of Yangshuo, China.In July 2011, Rinaudo became an entrepreneur, specializing robotics and drones, with over nine patents under his name. He founded Romotive that made inexpensive small robots using mobile phones as their computing system, machine vision system and wireless communication system.Romotive was pivoted into Zipline International in 2014 to design and manufacture make drones for the delivery of critical medical supplies in remote parts of the world.
After graduating in economics and biotech at Harvard in 2009, Keller Rinaudo joined BCG in San Francisco but left to become a professional rock climber in November 2010. He has climbed alpine cliffs in France, underwater caves in Kentucky and the limestone towers of Yangshuo, China.In July 2011, Rinaudo became an entrepreneur, specializing robotics and drones, with over nine patents under his name. He founded Romotive that made inexpensive small robots using mobile phones as their computing system, machine vision system and wireless communication system.Romotive was pivoted into Zipline International in 2014 to design and manufacture make drones for the delivery of critical medical supplies in remote parts of the world.
Founded in 2013 in Singapore, VVNP is a future-food solutions-orientated investor with a special interest in science-based companies that have the ability to scale global solutions, especially within Asia. It invests from seed stage to Series C level. Typical investments range from $300,000 to $3m and the investor has launched two funds to date. The first raised $40m and invested in seven companies globally, while the second was created in 2020, targeting $150m in total investment.The VC’s most recent investments include a €271,000 pre-seed investment round in Dutch poultry animal welfare biotech In Ovo in March 2021, and leading the as-yet-uncompleted 6m Swiss franc (approximately $6.56m) seed round in Swiss biotech SwissDeCode in January 2021 – a company that applies DNA testing to food traceability.
Founded in 2013 in Singapore, VVNP is a future-food solutions-orientated investor with a special interest in science-based companies that have the ability to scale global solutions, especially within Asia. It invests from seed stage to Series C level. Typical investments range from $300,000 to $3m and the investor has launched two funds to date. The first raised $40m and invested in seven companies globally, while the second was created in 2020, targeting $150m in total investment.The VC’s most recent investments include a €271,000 pre-seed investment round in Dutch poultry animal welfare biotech In Ovo in March 2021, and leading the as-yet-uncompleted 6m Swiss franc (approximately $6.56m) seed round in Swiss biotech SwissDeCode in January 2021 – a company that applies DNA testing to food traceability.
Yueyin Venture Capital was founded in 2015 in Beijing. It manages total assets worth US$300m, with investments in 22 companies. The VC focuses mainly in the healthcare, pharmaceutical and biotech sectors.
Yueyin Venture Capital was founded in 2015 in Beijing. It manages total assets worth US$300m, with investments in 22 companies. The VC focuses mainly in the healthcare, pharmaceutical and biotech sectors.
Future Food Asia 2021: Two winners take home $100,000 each
Agrifood startups, corporations and investors urged to collaborate and take action, tackling challenges in nutrition and climate change
How Sequoia Capital China is helping its portfolio startups get through the Covid-19 crisis
The renowned investor is also making big bets on the opportunities that lie head
Meatable joins Royal DSM to create growth media specific for cell-based meat tech
The R&D between the biotech startup and fellow Dutch nutrition conglomerate could help scale and drive the commercial viability of lab-grown meat
Bluepha to boost PHA bioplastics production with $30m fresh funding
The Beijing-based startup aims to produce 10,000 tons of PHA bioplastic a year and build a SynBio community through its STEM education spinoff, Bluepha Lab
Biomilq: Creating cell-based mothers’ milk in a lab
With the aim of helping women struggling to breastfeed, Bill Gates-backed Biomilq is disrupting the $45bn baby formula industry developing lab-grown breast milk from mammary epithelial cells
Oscillum: The intelligent label to reduce food waste
The Spanish biotech startup has developed sensors embedded in biodegradable plastic labels to monitor “product freshness” beyond expiration dates, helping consumers to avoid food waste and save money
Infinited Fiber: Producing biofibers for fashion to move toward circular economy
Supported by H&M, Adidas and textile manufacturers, Infinited Fiber is helping the world’s second most polluting industry go greener by turning industrial waste into regenerated biomaterials
“From a record year to a tragic year” – Investor Eneko Knorr on Spain’s 2020 startup funding
Startups should focus on profitability but for investors with leeway, there are still great opportunities, says Spanish angel investor Eneko Knorr. He shares his outlook, top picks and advice on riding out the Covid-19 crisis
iCell: Upcycling nutrients from wastewater
Hong Kong-based iCell Sustainable Nutrition makes single-cell proteins with wastewater from food and beverage factories, generating revenue and purifying the water for safe discharge or reuse
Forward Fooding: Ranking the world's agrifood startups on success and sustainability
The collaborative platform has opened applications for its FoodTech500 global ranking of agrifood startups; counts over 7,000 startups and scaleups mapped so far
European agritech is the new global focus, as startup investments nearly doubled in 2019
Last year, European agritech surpassed China for the first time in investments received, with openings in multiple subsectors from big data to blockchain
Portugal oceantech II: Single-minded efforts to build an ecosystem of international reference
With dedicated accelerators and investment programs, supported by the EU’s vote of confidence, Portugal appears on track to lead in oceantech
String Bio: Asia's first startup to harness methane gas for protein production
Using bacteria to turn the harmful greenhouse gas into a purer form of protein, String Bio is raising Series B funding to scale production
Want to cut plastic packaging? Notpla's edible seaweed sachets are an option
From its edible whiskey “bubbles” to biodegradable Teflon-free container liners, Notpla seeks to replace single-use plastic and help food companies boost their green credentials
South Summit 2021: Martin Varavsky, Leandro Sigman on post-Covid healthcare trends
Serial entrepreneur Martin Varavsky and Insud Pharma Chairman Leandro Sigman share their thoughts and projections on the future of health tech
Sorry, we couldn’t find any matches for“Xtrem Biotech”.
POPULAR DATABASE
